News

Approximately 240 subjects were randomized. The primary objectives of the four-week study were to determine the efficacy and safety of its lithium carbonate product (lithium QD) compared to

Teva is currently in patent litigation concerning this product in the US district court for the District of Delaware. In connection with the pending patent litigation, Teva has

The trial, which is aimed at determining the pharmacokinetics of two doses of Zenvia (dextromethorphan/quinidine) in the treatment of pseudobulbar affect (PBA) in patients with amyotrophic lateral sclerosis

A 12-week, placebo controlled, double blind, randomised Phase IIa study was designed to explore whether clinically relevant LDL-cholesterol lowering can be achieved without adversely affecting the heart, bone,

After receiving technical clearance of the electronic common technical document from the FDA, the regulatory review period will begin, the German drug discovery company said. Jens Schneider-Mergener, CEO

Akesis will initiate the trial after FDA approval. The trial will be performed by dgd Research of San Antonio and will be designed to measure efficacy (using the

In a Phase III, multi-center, double-blind trial, 257 patients with diabetic foot infections without concomitant osteomyelitis were randomized to receive either 500mg of ceftobiprole administered intravenously every eight

Data for HE3286 has showed significant benefit in the wistar rat model of dinitrobenzene sulfonic acid (DNBS) induced colitis, a preclinical model widely used in industry and academia

The program used RNAi therapeutics directed to the disease target proprotein convertase subtilisn/kexin type 9. The data shows that in vivo systemic administration of an RNAi therapeutic in